© 2019 GaiaCann Inc.

  • Facebook
  • Instagram

GaiaCann's advanced medical researchdiverse genetics and superior quality control management allow us to take a true scientific approach focused on creating a positive and unique patient experience.


Our facilities highlight proven growing techniques designed to complement the Northern climate while operating to produce nothing short of excellence. GaiaCann's operational team is dedicated to quality practice designed to enhance the natural growth of the cannabis plant while conserving energy and delivering a high quality, consistent product. 


With true quality care in mind, GaiaCann's state-of-the-art facilities will produce crafted cannabis that not only meets but exceeds medical and compliance grade standards. GaiaCann is a current applicant under The Cannabis Act. With rapid expansion in progress we expect to have our flagship facility operational in 2020.

From Plant To Purity

Our purpose-built ISO and cGMP compliant facility, coupled with our proprietary extraction methods and uniquely experienced team will allow GaiaCann to deliver pure, safe and precisely-dosed cannabis concentrates and refined and pure isolates.   


GaiaCann has developed a partnership with a talented group of certified clinical trial experts with more than 15 years of experience in the industry. The processes and procedures used,  exceed the most stringent government guidelines for conducting Canadian research. Medicor Research will work with drug discovery specialists on our team to take our discoveries from plant to pharmacy. 


GaiaCann is launching a Full-Service analytical testing lab that will service Licenced Producers with mandatory testing. GaiaCann's services include a Wide spectrum of testing using state of the art modern equipment. We provide reports that are Health Canada compliant. The facility is expected to be operational in 2020.